Ungar, PhD, a professor at Penn Engineering, notes that while clinical trials are excellent at flagging high-risk safety concerns, they often overlook the day-to-day symptoms that bother patients the most
Neuroprotective effect of STAZN, a novel azulenyl nitrone antioxidant, in focal cerebral ischemia in rats: dose-Response and therapeutic window
CONTENTS status epilepticus Treatment part #1 : The first hour Treatment part #2a: Causes & investiation Treatment part #2b: Checklist for ICU care Treatment part #3 : Ongoing strategy for refractory status epilepticus (Other topics) pharmacology of antiseizure medications Core antiseizure medications in the ICU Anesthetics Other medications treatment part 1, the first hour treatment part 1, the first hour This algorithm is designed to control an ongoing generalized tonic-clonic seizure within hemorrhagic)
Sleep-dependent activity of T cells and regulatory T cells
Effects of adding L-arginine orally to standard therapy in patients with COVID-19: a randomized, double-blind, placebo-controlled, parallel-group trial